Flywheel: Medical Imaging Data Company Raises $54 Million

By Amit Chowdhry • Jul 6, 2023

Flywheel – a leading medical imaging data and AI platform – announced it raised $54 million in Series D funding with more to come soon. And this latest funding round was co-led by Novalis LifeSciences LLC and NVentures (NVIDIA’s venture capital arm). Microsoft also joined the funding round along with insiders Invenshure, 8VC, Beringea, Hewlett Packard Enterprise, Intuitive Ventures, iSelect, Gundersen Health System, Seraph, and Great North Ventures.

This funding round will enable Flywheel’s continued growth in its two primary markets, public sector healthcare and pharmaceutical companies while accelerating expansion in other markets, including providers, payers, system integrators, and software companies seeking to harness the value of their data for AI development. And this latest funding round will also help Flywheel extend its global reach into key geographies, particularly across Europe.

Marijn Dekkers, chairman and founder of Novalis LifeSciences and former CEO of Bayer AG and Thermo Fisher Scientific, will join the company’s board of directors.

KEY QUOTES:

“Flywheel’s products transform healthcare innovation by empowering organizations to efficiently and securely ingest, curate and share medical imaging data for accelerated research and AI development.”

— Flywheel CEO Jim Olson

“We are excited to lead this financing round at Flywheel. We believe Flywheel’s unique software solutions enable the smarter use and interpretation of the vast amounts of information associated with large numbers of medical imaging scans. We are particularly excited about the ability of these tools to drive more efficient and faster drug development processes in the biopharma industry.”

— Marijn Dekkers, chairman and founder of Novalis LifeSciences

“The application of AI has led to the discovery of new drugs, identifying patterns in disease, and improvements in patient care. Flywheel uses AI to unlock the value within medical imaging data, signaling the continued benefit of applying AI across the healthcare industry.”

— Mohamed “Sid” Siddeek, Head of NVentures, NVIDIA